The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia.

Gonçalves-Pereira J, Costa L, Silva I, Simões A, Froes F, Mergulhão P, Varela Ramos P, Leal D, Alves R, Custódio M, Gomes A

Open source

DOI
10.1016/j.pulmoe.2022.08.003
Published
2023 May-Jun
Container
Pulmonology
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pulmoe.2022.08.003,
  title = {The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia.},
  author = {Gonçalves-Pereira J and Costa L and Silva I and Simões A and Froes F and Mergulhão P and Varela Ramos P and Leal D and Alves R and Custódio M and Gomes A},
  year = {2023},
  journal = {Pulmonology},
  doi = {10.1016/j.pulmoe.2022.08.003},
  url = {https://doi.org/10.1016/j.pulmoe.2022.08.003}
}

RIS

TY  - JOUR
TI  - The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia.
AU  - Gonçalves-Pereira J
AU  - Costa L
AU  - Silva I
AU  - Simões A
AU  - Froes F
AU  - Mergulhão P
AU  - Varela Ramos P
AU  - Leal D
AU  - Alves R
AU  - Custódio M
AU  - Gomes A
PY  - 2023
JO  - Pulmonology
DO  - 10.1016/j.pulmoe.2022.08.003
UR  - https://doi.org/10.1016/j.pulmoe.2022.08.003
ER  -

APA

J, G., L, C., I, S., A, S., F, F., P, M., P, V. R., D, L., R, A., M, C., & A, G. (2023). The benefit of macrolide therapy in patients with pneumococcal pneumonia is only present in patients with bacteremia.. Pulmonology. https://doi.org/10.1016/j.pulmoe.2022.08.003

Source records